Piltdown Proves a Point

In 1908, a workman digging in a gravel pit in the Sussex hamlet of Piltdown discovered a fragment of a human cranium's parietal bone. He delivered it to Charles Dawson, an amateur geologist and antiquarian, thus setting off one of the most controversial and bizarre episodes in the study of human paleontology. For the next 40 years Eoanthropus clawsoni was a respected member of modern man's family tree, and a representation of this distinguished ancestor stood proudly in the American Museum of Na

Written byCharles Blinderman
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

The resolution of the question of whether science does map the truth of reality or whether it is just another myth has consequences for us in our daily lives. In the 1920s, fundamentalists wanted to outlaw the teaching of evolution in public schools; today, they want to give creationism equal time with evolution.

For close to 40 years, Eoanthropus dawsoni, a.k.a. Piltdown Man, was taught as fact. His australopithecine and pithecanthropine relatives are still taught as fact. If they are really as mythical as he was, then it seems the just thing to do would be to give equal time to competing facts or myths. If science is nothing more than myth, then biblical stories are agreeable alternatives and render, serendipitously, more wholesome ethics.

The paleontologist Earnest Hooton pushed the Piltdown case aside as unique; but the creationists pulled it back as typical of what evolutionists always do: deceiving themselves ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies